29 Skin Cancer

Skin Cancer

19

THE GEC ESTROHANDBOOKOF BRACHYTHERAPY | Part II Clinical Practice Version 1 - 30/04/2017

43. Allan E, Stanton A, Pye D, et al. Fractionated high dose rate brachytherapy moulds – a precise treatment for carcinoma of the pinna. Radiother Oncol , 48 (1998), pp. 277–281 44. Köhler-Brock A, Prager W, Pohlmann S, Kunze S. The indications for and results of HDR afterloading therapy in diseases of the skin and mucosa with standardized surface applicators (the Leipzig applicator). Strahlenther Onkol. 1999;175(4):170-4. 45. Gauden R, Pracy M, Avery AM, Hodgetts I, Gauden S. HDR brachytherapy for superficial non-melanoma skin cancers. J Med Imaging Radiat Oncol. 2013; 57:212-17. 46. Arenas M, Arguis M, Diez-Presa L, et al. Hypofractionated high-dose- rate plesiotherapy in nonmelanoma skin cancer treatment. Brachytherapy 2015;14:859-865. 47. Tormo A, Celada F, Rodriguez S, et al. Non-melanoma skin cancer treated with HDR Valencia applicator: Clinical outcomes. J Contemp Brachytherapy 2014; 6 (2):167-172. 48. Delishaj D, Laliscia C, Manfredi B et al. Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series. J Contemp Brachytherapy 2015; 7(6):437-44. 49. Guix B, Finestres F, Tello JI, et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys 2000; 47: 95-102. 50. Montero A, Hernanz R, Capuz AB, et al. High-dose-rate plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer. Clin Transl Oncol 2009; 11:760-4. 51. Maroñas M, Guinot JL, Arribas L, et al. Treatment of facial cutaneous carcinoma with high-dose rate contact brachytherapy with customized molds. Brachytherapy 2011;10(3):221-7. 52. Bujor L, Mareco V, Abrunhosa-Branquinho AN et al. CT-guided high-dose- rate interstitial Brachytherapy in eyelid carcinomas: a retrospective study. Radiat Oncol 2014. 111:Suppl 1. Page 420. 53. Azad S, Choudhary V. Treatment results of high dose rate interstitial brachytherapy in carcinoma of eyelid. J Cancer Res Ther 2011; 7:157-61. 54. Ballester-Sanchez R, Pons-Llanas O, Candela-Juan C et al. Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses. J Contemp Brachytherapy 2016; 8(1):48-55. 55. Garibyan L, Cotter SE, Hansen JL, et al. Palliative treatment for in-transit cutaneous metastases of Merkel cell carcinoma using surface-mold computer- optimized high-dose-rate brachytherapy. Cancer J. 2013; 19:283-7. 56. Kasper ME, Richter S, Warren N, Benda R, Shang C, Ouhib Z. Complete response of endemic Kaposi sarcoma lesions with high-dose-rate brachytherapy: treatment method, results, and toxicity using skin surface applicators. Brachytherapy 2013; 12:495-9. 57. De Simone JA, Guenova E, Carter JB, et al. Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2013; 69:61-5.

ACKNOWLEDGEMENTS The authors of this chapter are much indebted to J.J. Mazeron, one of the two authors of the original version of the chapter on Skin Cancer in the first edition of the GEC-ESTRO Handbook of Brachytherapy 2002.

AUTHORS José Luis Guinot, MD Head of Brachytherapy Department of Radiation Oncology Fundacion Instituto Valenciano de Oncologia (IVO) Valencia, Spain

José Pérez-Calatayud, PhD Head Medical Physics Radiotherapy Department Hospital La Fe-IRIMED Valencia, Spain

Erik Van Limbergen, MD, PhD Professor of Radiation Oncology Department of Radiation Oncology University Hospital Gasthuisberg Leuven, Belgium